Sign Up to like & get
recommendations!
2
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.768956
Abstract: Background Lymphopenia is a known significant factor for treatment outcome in cancer patients, with underlying risk factor poorly understood in breast cancer. We hypothesize that the effective dose to the circulating immune cells (EDIC) which…
read more here.
Keywords:
ril;
post prert;
breast cancer;
plc ... See more keywords